Cathy Eng, M.D., is David H. Johnson Chair in Surgical and Medical Oncology, director of the Vanderbilt-Ingram Cancer Center Young Adult Cancers Program, and a professor of medicine at Vanderbilt University Medical Center. Her primary clinical research interests include clinical trials involving innovative drugs for the treatment of colorectal, anal and appendiceal cancers.